St. Jude Medical STJ
-
Medtronic Wraps up Fiscal 2012 With Solid 4Q
… saw slight declines in its share of de novo CRT-D implants, as practitioners have begun switching over to St . Jude Medical 's STJ new Unify Quadra implant. While management contends that this share decline is likely temporary, based on usage …
-
Why We Think St . Jude Is Undervalued
… process, we perform a rigorous discounted cash-flow methodology that dives into the true intrinsic worth of companies. In St . Jude 's ( STJ ) case, we think the firm is undervalued. We think it is fairly valued at $52 per share. For some background, we think …
-
An Exciting New Technology That Could Take Pressure Off St . Jude Medical
… This is something I had never heard about until St . Jude Medical ( STJ ) mentioned it at their February analyst day after ..... clarify the significance of this new technology for St . Jude Medical 's growth program, we estimate that as many as …
-
St . Jude Medical ([[ STJ ]] +2.1%) ticks higher after being upgraded to Buy at Goldman. The firm cites share gains in its core markets and entrance into new therapeutic categories, which could ...
St . Jude Medical ( STJ +2.1% ) ticks higher after being upgraded to Buy at Goldman. The firm cites share gains in its core markets and entrance into …
-
Update: Bullish Case For Boston Scientific
… of home monitoring capabilities. Home monitoring has given St Jude ( STJ ) and Medtronic ( MDT ) a way to differentiate their product ..... bullish case for BSX and provide for competitive advantages over STJ and MDT products. Note: Medical devices are extremely complicated …
-
St . Jude's Riata lead performed poorly in study
May 10 (Reuters) - St . Jude Medical Inc's Riata defibrillator lead, which was recalled late last year, performed "significantly worse" than a competing lead called Quattro, sold by competitor Medtronic Inc, in a large study, researchers said.
-
New J&J (JNJ) CEO Alex Gorsky is looking to strengthen the company's medical-device unit via takeovers, he tells Bloomberg in an interview. "We remain committed to cardiovascular," Gorsky says, ...
… takeovers, he tells Bloomberg in an interview. "We remain committed to cardiovascular," Gorsky says, despite sales shrinking 44% since 2006. On the analyst wish list are Edwards Lifesciences ( EW ) and St . Jude Medical ( STJ ). 1 comment!
-
St Jude Riata heart device problems persist - study
CHICAGO, May 1 (Reuters) - St Jude Medical Inc published a report on its website on Tuesday that shows problems with wires that carry electricity from implantable defibrillators to the heart have persisted in the last 3 months.
-
Bullish Case For Boston Scientific Corp
… BSX ) market capitalization $9 billion. Industry related companies Medtronic ( MDT ) market capitalization of $39 billion St Jude ( STJ ) market capitalization of $12 billion In my prior analysis of Westport Innovations ( WPRT ) on Seeking Alpha ( article can …
-
Sapien Drives Revenue and Earnings Growth for Edward Lifesciences in 1Q
… revenue growth to 67% year over year. For surgical heart valves, Edwards saw a 3% decline following the introduction of St . Jude 's STJ Trifecta tissue valve last year. Nonetheless, Edwards benefited from the product mix that shifted toward higher-margin …